|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03136458 |
|
Date of registration:
|
24/04/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)
PAIR |
|
Scientific title:
|
Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR Trial) |
|
Date of first enrolment:
|
January 1, 2016 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
https://clinicaltrials.gov/show/NCT03136458 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Colombia
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Hospitalized in general wards, emergency room or ambulatory consult.
- 18 years or older.
- Requires computerized tomography with endovenous contrast.
- Glomerular filtration rate between 30 - 60 mL/minute/1,73 m2.
- Patient accepts and signs informed consent.
Exclusion Criteria:
- Allergic to contrast media.
- Unable to accept or sign informed consent.
- Did not received endovenous saline before and/or after the contrast procedure.
- Peripheral arterial disease.
- Bilateral upper extremities lymph node dissection or any situation impending arterial
pressure taking.
- Morbid obesity (body mass index 40 or more).
- Arterial systolic pressure greater than 175 mmHg.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Contrast-induced Nephropathy
|
|
Intervention(s)
|
|
Procedure: Ischemic preconditioning
|
|
Drug: Endovenous normal saline
|
|
Primary Outcome(s)
|
|
Contrast induced nephropathy incidence
[Time Frame: 48 to 72 hours]
|
|
Secondary Outcome(s)
|
|
Adverse effects to preconditioning.
[Time Frame: 0 to 72 hours.]
|
|
Secondary ID(s)
|
|
ValledelLili
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|